Journey Colab
Dr. Bogenschutz is a Professor of Psychiatry at NYU Grossman School of Medicine, and Director of the newly established NYU Langone Center for Psychedelic Medicine. He has been conducting clinical research with psychedelics since 2011, including trials of psilocybin-assisted treatment of alcohol use disorder and MDMA-assisted treatment of PTSD. He is also conducting NIH-funded studies on alcohol use disorder and post-traumatic stress disorder.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Journey Colab
Journey Colab is pursuing FDA approval of psychedelic therapies to heal individual mental health and strengthen communities. They plan to build a portfolio of plant-identical compounds. Their first compound in development is mescaline.